Over last month, three facilities inspected and cleared with 'Zero 483' status
Strides Shasun announced that its Active Pharmaceutical Ingredients manufacturing site in Puducherry was recently inspected by USFDA and the approval was renewed with 'Zero 483' status.
Over the last month, three facilities were inspected by USFDA and cleared with 'Zero 483' status.
-API facility at Cuddalore
-Oral Dosage facility at Puducherry
-API facility at Puducherry.
The Company's flagship facility (KRSG Gardens) in Bangalore was also inspected and cleared by USFDA in June 2016 without any 483 observations.
With this, the Company's last four USFDA inspections were successfully completed without any observations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
